Literature DB >> 19692435

Multiple sclerosis and neurofibromatosis type 1: report of seven patients from Iran.

M Etemadifar1, F Fatehi, M A Sahraian, A Borhanihaghighi, P M Ardestani, M Kaji-Esfahani, A H Maghzi.   

Abstract

INTRODUCTION: Co-occurrence of multiple sclerosis (MS) and neurofibromatosis type 1 (NF1) is rare. CASE REPORTS: In this study, we describe the clinical and neuroimaging features of seven patients with NF1 and MS. In our patients, six patients with MS were women, in all of them history of NF1 existed. Three of our patients had primary progressive, one had secondary progressive MS, and three relapsing-remitting MS. Optic neuritis as presenting symptoms was seen in three patients, and motor manifestation as presenting symptom was observed in three patients. The risk of having both NF1 and MS seemed to be higher than would be expected based on the prevalence rates of the two diseases in the general population.
CONCLUSION: The findings of this study suggest a possible casual relationship between MS and NF1, indicating higher risk of MS among patients with NF1.

Entities:  

Mesh:

Year:  2009        PMID: 19692435     DOI: 10.1177/1352458509106612

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  7 in total

1.  The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients.

Authors:  Saam Noroozi; Hossein Ali Ebrahimi Meimand; Mohammad Kazemi Arababadi; Nouzar Nakhaee; Gholamreza Asadikaram
Journal:  Mol Neurobiol       Date:  2016-03-31       Impact factor: 5.590

2.  Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS).

Authors:  Silvia Ciotti; Antonella Cometa; Claudia De Carlo; Giancarlo Martini; Andrea Marona; Laura Filippetti; Diego Carducci; Silvano Baratta; Mauro Zampolini; Francesco Corea
Journal:  Eur J Case Rep Intern Med       Date:  2021-02-03

3.  Cooccurrence of Multiple Sclerosis and Idiopathic Basal Ganglia Calcification.

Authors:  M Abedini; N Karimi; N Tabrizi
Journal:  Case Rep Med       Date:  2015-08-16

4.  Relapsing Remitting Multiple Sclerosis in an Iranian Patient with Neurofibromatosis Type I.

Authors:  Nafiseh Mohebi; Mehdi Moghaddasi; Zaribafian Maryam
Journal:  Neurol Int       Date:  2015-09-24

5.  Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis.

Authors:  Chinwe C Madubata; Margaret A Olsen; Dustin L Stwalley; David H Gutmann; Kimberly J Johnson
Journal:  Genet Med       Date:  2014-06-05       Impact factor: 8.822

6.  Neurofibromatosis I and multiple sclerosis.

Authors:  Christina Bergqvist; François Hemery; Salah Ferkal; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2020-07-14       Impact factor: 4.123

7.  Primary Progressive Multiple Sclerosis in a Portuguese Patient With Neurofibromatosis Type 1.

Authors:  Inês Carvalho; Miguel Quintas-Neves; Joana Pinto; Ana Filipa Santos; João Pereira
Journal:  Cureus       Date:  2021-12-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.